Dr. Stanley M. Lemon is the John Sealy Distinguished University Chair and Director of the Institute for Human Infections and Immunity at the University of Texas Medical Branch at Galveston.

He received his undergraduate A.B. degree in biochemical sciences from Princeton University summa cum laude, and his M.D. with honor from the University of Rochester. He completed postgraduate training in internal medicine and infectious diseases at the University of North Carolina at Chapel Hill, and is board certified in both.

From 1977 to 1983, he served with the U.S. Army Medical Research and Development Command, directing the Hepatitis Laboratory at the Walter Reed Army Institute of Research. He joined the faculty of the University of North Carolina School of Medicine in 1983, serving first as Chief of the Division of Infectious Diseases, and then Vice Chair for Research of the Department of Medicine. In 1997, Dr. Lemon moved to the University of Texas Medical Branch as Professor and Chair of the Department of Microbiology & Immunology. He was appointed Dean pro tem of the School of Medicine in 1999, and subsequently served as permanent Dean of Medicine from 2000 to 2004. As dean, Dr. Lemon led the School of Medicine through a period of impressive expansion in its biodefense and infectious disease related research activities, and still serves as principal investigator of the Galveston National Laboratory, one of two NIH-funded National Biocontainment Laboratories. Dr. Lemon's personal research interests relate to the molecular virology and pathogenesis of the positive-stranded RNA virus responsible for hepatitis C. He directs an NIH-funded Hepatitis C Cooperative Research Center and leads a multi-faceted research program on hepatitis C. He has published over 180 papers, and numerous textbook chapters related to hepatitis and other viral infections.

Dr. Lemon has had a longstanding interest in anti-viral and vaccine development, and has served previously as chair of the Anti-Infective Drugs Advisory Committee, and the Vaccines and Related Biologics Advisory Committee, of the U.S. Food and Drug Administration. He is past chair of the Steering Committee on Hepatitis and Poliomyelitis of the World Health Organization's Programme on Vaccine Development, the Board of Scientific Councilors of the National Center for Infectious Diseases of the Center for Disease Control and Prevention, and the Forum on Microbial Threats of the Institute of Medicine. He presently serves as a member of the U.S. Delegation of the U.S.-Japan Cooperative Medical Sciences Program. He recently co-chaired an Institute of Medicine study committee on “Globalization, Biosecurity, and the Future of the Life Sciences” and in 2005 was appointed to the National Science Advisory Board on Biosecurity.